Works matching AU Zang, Dae

Results: 88
    1
    2
    3
    4

    Safety and effectiveness of aflibercept in combination with FOLFIRI in Korean patients with metastatic colorectal cancer who received oxaliplatin-containing regimen.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 3, p. 1131, doi. 10.1007/s00432-022-03946-x
    By:
    • Beom, Seung-Hoon;
    • Kim, Jong Gwang;
    • Baik, Seung Hyuk;
    • Shin, Seong Hoon;
    • Park, Inkeun;
    • Park, Young Suk;
    • Lee, Myung-Ah;
    • Lee, Soohyeon;
    • Jeon, So-Yeon;
    • Han, Sae-Won;
    • Kang, Myoung Hee;
    • Oh, Jisu;
    • Kim, Jin Soo;
    • Kim, Jin Young;
    • Ahn, Mi Sun;
    • Zang, Dae Young;
    • Bae, Byung-Noe;
    • Jo, Hong Jae;
    • Kim, Hee Kyung;
    • Kim, Jung-Han
    Publication type:
    Article
    5
    6

    Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG).

    Published in:
    Gastric Cancer, 2018, v. 21, n. 5, p. 819, doi. 10.1007/s10120-018-0806-1
    By:
    • Jung, Minkyu;
    • Ryu, Min-Hee;
    • Oh, Do Youn;
    • Kang, Myounghee;
    • Zang, Dae Young;
    • Hwang, In Gyu;
    • Lee, Keun-Wook;
    • Kim, Ki Hyang;
    • Shim, Byoung Yong;
    • Song, Eun Kee;
    • Sym, Sun Jin;
    • Han, Hye Sook;
    • Park, Young Lee;
    • Kim, Jin Soo;
    • Lee, Hyun Woo;
    • Lee, Moon Hee;
    • Koo, Dong-Hoe;
    • Song, Hong Suk;
    • Lee, Namsu;
    • Yang, Sung Hyun
    Publication type:
    Article
    7

    Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11.

    Published in:
    Gastric Cancer, 2018, v. 21, n. 5, p. 802, doi. 10.1007/s10120-018-0794-1
    By:
    • Kim, Hyeong Su;
    • Ryu, Min-Hee;
    • Zang, Dae Young;
    • Park, Sook Ryun;
    • Han, Boram;
    • Kang, Won Ki;
    • Rha, Sun Young;
    • Jung, Minkyu;
    • Kim, Jin-Soo;
    • Kang, Byung Woog;
    • Lee, Kyung-Hee;
    • Rho, Sang-Young;
    • Kim, Jung Han;
    • Kim, Kab Choong;
    • Cho, Ji Woong;
    • Choi, Dae Ro;
    • Lim, Hyun;
    • Kang, Ho Suk;
    • Soh, Jae Seung;
    • Kim, Min-Jeong
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Clinical Practice Guidelines for Gastric Cancer in Korea: An Evidence-Based Approach.

    Published in:
    Journal of Gastric Cancer, 2014, v. 14, n. 2, p. 87, doi. 10.5230/jgc.2014.14.2.87
    By:
    • Jun Haeng Lee;
    • Jae G. Kim;
    • Hye-Kyung Jung;
    • Jung Hoon Kim;
    • Woo Kyoung Jeong;
    • Tae Joo Jeon;
    • Joon Mee Kim;
    • Young Il Kim;
    • Keun Won Ryu;
    • Seong-Ho Kong;
    • Hyoung-Il Kim;
    • Hwoon-Yong Jung;
    • Yong Sik Kim;
    • Dae Young Zang;
    • Jae Yong Cho;
    • Joon Oh Park;
    • Do Hoon Lim;
    • Eun Sun Jung;
    • Hyeong Sik Ahn;
    • Hyun Jung Kim
    Publication type:
    Article
    19
    20
    21

    Cytogenetic and Molecular Failure at 12 Months will be the Optimal Time Point for BCR-ABL1 Tyrosine Kinase Domain Mutation Analysis in Patients with Chronic Myeloid Leukemia: The Analysis Based on 2013 European LeukemiaNet Recommendation.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S17, doi. 10.1016/j.clml.2017.09.045
    By:
    • Hee-Je Kim;
    • Hea-Lyun Yoo;
    • Won-Sik Lee;
    • Hyeong-Joon Kim;
    • Jee Hyun Kong;
    • Yunsuk Choi;
    • Young Rok Do;
    • Jae-Yong Kwak;
    • Sukjoong Oh;
    • Sung Hyun Kim;
    • Jeong-A. Kim;
    • Dae Young Zang;
    • Yeung-Chul Mun;
    • Young-Woong Won;
    • Sung-Eun Lee;
    • Dong-Wook Kim
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35

    Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16).

    Published in:
    Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211042812
    By:
    • Han, Hye Sook;
    • Kim, Bum Jun;
    • Jee, Hee-Jung;
    • Ryu, Min-Hee;
    • Park, Se Hoon;
    • Rha, Sun Young;
    • Kim, Jong Gwang;
    • Bae, Woo Kyun;
    • Lee, Keun-Wook;
    • Oh, Do-Youn;
    • Kim, In-Ho;
    • Sym, Sun Jin;
    • Oh, So Yeon;
    • Kim, Hyeong Su;
    • Byun, Ji-Hye;
    • Kim, Dong Sook;
    • Suh, Young Ju;
    • An, Hyonggin;
    • Zang, Dae Young
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer (STARGATE).

    Published in:
    Cancer Medicine, 2023, v. 12, n. 7, p. 7784, doi. 10.1002/cam4.5536
    By:
    • Ryu, Min‐Hee;
    • Lee, Kyung Hee;
    • Shen, Lin;
    • Yeh, Kun‐Huei;
    • Yoo, Changhoon;
    • Hong, Young Seon;
    • Park, Young Iee;
    • Yang, Sung Hyun;
    • Shin, Dong Bok;
    • Zang, Dae Young;
    • Kang, Won Ki;
    • Chung, Ik‐Joo;
    • Kim, Yeul Hong;
    • Ryoo, Baek‐Yeol;
    • Nam, Byung‐Ho;
    • Park, Young Soo;
    • Kang, Yoon‐Koo
    Publication type:
    Article
    50